HK1254684A1 - 預測前列腺癌風險及前列腺腺體體積的方法和裝置 - Google Patents

預測前列腺癌風險及前列腺腺體體積的方法和裝置

Info

Publication number
HK1254684A1
HK1254684A1 HK18113665.7A HK18113665A HK1254684A1 HK 1254684 A1 HK1254684 A1 HK 1254684A1 HK 18113665 A HK18113665 A HK 18113665A HK 1254684 A1 HK1254684 A1 HK 1254684A1
Authority
HK
Hong Kong
Prior art keywords
apparatuses
methods
prostate
predicting risk
gland volume
Prior art date
Application number
HK18113665.7A
Other languages
English (en)
Inventor
Andrew J Vickers
Peter T Scardino
Hans Lilja
Vincent Linder
David Steinmiller
Original Assignee
Oy Arctic Partners Ab
Opko Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oy Arctic Partners Ab, Opko Diagnostics Llc filed Critical Oy Arctic Partners Ab
Publication of HK1254684A1 publication Critical patent/HK1254684A1/zh

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Theoretical Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Evolutionary Computation (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Software Systems (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioethics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Genetics & Genomics (AREA)
HK18113665.7A 2012-03-05 2018-10-25 預測前列腺癌風險及前列腺腺體體積的方法和裝置 HK1254684A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261606554P 2012-03-05 2012-03-05
FI20125238 2012-03-05

Publications (1)

Publication Number Publication Date
HK1254684A1 true HK1254684A1 (zh) 2019-07-26

Family

ID=65441575

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18113665.7A HK1254684A1 (zh) 2012-03-05 2018-10-25 預測前列腺癌風險及前列腺腺體體積的方法和裝置

Country Status (8)

Country Link
JP (1) JP2020073885A (zh)
KR (1) KR102303487B1 (zh)
DE (1) DE202013012731U1 (zh)
DK (1) DK2823427T3 (zh)
ES (1) ES2859975T3 (zh)
HK (1) HK1254684A1 (zh)
HU (1) HUE054194T2 (zh)
PT (1) PT2823427T (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022225000A1 (ja) 2021-04-21 2022-10-27 伊藤 公一 甲状腺疾患の診断に関する参考情報を提供する情報処理装置
US12100143B2 (en) * 2022-05-13 2024-09-24 City University Of Hong Kong Label-free liquid biopsy-based disease model, analytical platform and method for predicting disease prognosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2152417T3 (en) * 2007-05-04 2018-08-06 Opko Diagnostics Llc APPARATUS AND PROCEDURE FOR ANALYSIS IN MICROFLUID SYSTEMS
EP2558203B1 (en) * 2010-04-16 2024-06-05 Opko Diagnostics, LLC Microfluidic sample analyzer and method of analyzing

Also Published As

Publication number Publication date
JP2020073885A (ja) 2020-05-14
DK2823427T3 (da) 2021-03-22
PT2823427T (pt) 2021-03-22
ES2859975T3 (es) 2021-10-04
HUE054194T2 (hu) 2021-08-30
DE202013012731U1 (de) 2019-01-16
KR102303487B1 (ko) 2021-09-16
KR20200103872A (ko) 2020-09-02

Similar Documents

Publication Publication Date Title
HK1206837A1 (zh) 預測前列腺癌風險及前列腺腺體體積的方法和裝置
IL254255A0 (en) A method for predicting the likelihood of clinical outcome for a patient with prostate cancer
HK1213771A1 (zh) 治療癌症的方法
HK1206431A1 (zh) 癌症轉移的預後和治療方法
IL304337A (en) Antiandrogens for the treatment of castration-resistant prostate cancer without metastases
EP2847593A4 (en) METHODS FOR PREDICTING AND DETECTING THE RISK OF CANCER
SG10201703022SA (en) Method of prognosis and stratification of ovarian cancer
EP2867376A4 (en) TARGETED METHODS KNOWN AS RNA-SEQ AND MATERIALS FOR THE DIAGNOSIS OF PROSTATE CANCER
HK1259001A1 (zh) 癌症的預後和診斷方法
HK1220253A1 (zh) 診斷前列腺癌症的方法
ZA201604370B (en) Prostate cancer gene profiles and methods of using the same
IL232466A (en) Preparations and Methods for Prostate Cancer Analysis
HK1254684A1 (zh) 預測前列腺癌風險及前列腺腺體體積的方法和裝置
EP2932273A4 (en) METHODS OF DIAGNOSING AND TREATING PROSTATE CANCER
GB201202945D0 (en) Novel cancer therapies and methods